Nothing Special   »   [go: up one dir, main page]

DK0437128T3 - Anvendelse af et fluorquinolonderivat til fremstilling af et lægemiddel til behandling af pneumocystosis - Google Patents

Anvendelse af et fluorquinolonderivat til fremstilling af et lægemiddel til behandling af pneumocystosis

Info

Publication number
DK0437128T3
DK0437128T3 DK90403501.1T DK90403501T DK0437128T3 DK 0437128 T3 DK0437128 T3 DK 0437128T3 DK 90403501 T DK90403501 T DK 90403501T DK 0437128 T3 DK0437128 T3 DK 0437128T3
Authority
DK
Denmark
Prior art keywords
pneumocystosis
treatment
medicament
manufacture
hydrogen
Prior art date
Application number
DK90403501.1T
Other languages
English (en)
Inventor
Marc Gentilini
Anne Guyot
Michel Rosenheim
Original Assignee
Rhone Poulenc Sante
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Sante filed Critical Rhone Poulenc Sante
Application granted granted Critical
Publication of DK0437128T3 publication Critical patent/DK0437128T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/08—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis for Pneumocystis carinii

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Quinoline Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK90403501.1T 1989-12-11 1990-12-10 Anvendelse af et fluorquinolonderivat til fremstilling af et lægemiddel til behandling af pneumocystosis DK0437128T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8916324A FR2655545B1 (fr) 1989-12-11 1989-12-11 Nouvelle application therapeutique des derives des fluoroquinolones.

Publications (1)

Publication Number Publication Date
DK0437128T3 true DK0437128T3 (da) 1994-03-14

Family

ID=9388344

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90403501.1T DK0437128T3 (da) 1989-12-11 1990-12-10 Anvendelse af et fluorquinolonderivat til fremstilling af et lægemiddel til behandling af pneumocystosis

Country Status (16)

Country Link
US (1) US5179096A (da)
EP (1) EP0437128B1 (da)
JP (1) JPH03251532A (da)
KR (1) KR910011259A (da)
AT (1) ATE101518T1 (da)
AU (1) AU626743B2 (da)
CA (1) CA2031886A1 (da)
DE (1) DE69006707T2 (da)
DK (1) DK0437128T3 (da)
ES (1) ES2062464T3 (da)
FR (1) FR2655545B1 (da)
HU (1) HU207947B (da)
IE (1) IE64720B1 (da)
IL (1) IL96618A (da)
PT (1) PT96164B (da)
ZA (1) ZA909886B (da)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUT67395A (en) * 1993-07-13 1995-04-28 Somfai Method for the n-cyclopropylation of primary and secondary aromatic amines
US5707551A (en) * 1994-12-22 1998-01-13 Rhone-Poulenc Inc. Nonaqueous suspension concentrates of highly water-soluble solids
US5906962A (en) * 1994-12-22 1999-05-25 Rhodia Inc. Non-aqueous suspension concentrates of highly water-soluble solids
US6024979A (en) * 1995-06-06 2000-02-15 Solvay Animal Health, Inc. Oral veterinary composition containing a fluoroquinolone antibacterial agent possessing superior absorption properties and an extended duration of therapeutic antimicrobial blood levels, and a method of treating a microbial infection in a ruminant
US5686095A (en) * 1995-10-23 1997-11-11 Price, Jr.; Francis W. Method of treating canker sores
ES2319699T3 (es) * 1996-05-20 2009-05-11 Otsuka Pharmaceutical Co., Ltd. Remedio para la rosacea.
JPH10143977A (ja) 1996-09-10 1998-05-29 Sony Corp ディスク装置およびそれを用いたビデオカメラ装置
US6060474A (en) * 1998-11-05 2000-05-09 New York Society For The Relief Of The Ruptured And Crippled Maintaining The Hospital For Special Surgery Method for preventing scar tissue formation
US6346391B1 (en) 1999-07-22 2002-02-12 Trustees Of Tufts College Methods of reducing microbial resistance to drugs
KR101173696B1 (ko) * 2003-02-10 2012-08-13 바이엘 파마 악티엔게젤샤프트 플루오로퀴놀론의 국소 적용에 의한 호흡 기관의 세균성질환의 치료
WO2008019403A1 (en) * 2006-08-11 2008-02-14 University Of Medicine And Dentistry Of New Jersey Dual-sensitizer-containing luminescent compounds, conjugates, and uses thereof
WO2011088193A2 (en) 2010-01-13 2011-07-21 University Of Medicine And Dentistry Of New Jersey Fluorophore chelated lanthanide luminiscent probes with improved quantum efficiency

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1175836A (en) * 1977-09-20 1984-10-09 Marcel Pesson Production of 1,4-dihydroquinoline-3-carboxylic acid derivatives
GB1598915A (en) * 1977-09-20 1981-09-23 Bellon Labor Sa Roger 1,4-dihydro-quinoline-3-carboxylic acid derivatives process for their preparation and composition containing them
JPS5845426B2 (ja) * 1978-09-29 1983-10-08 杏林製薬株式会社 置換キノリンカルボン酸誘導体
JPS5630964A (en) * 1979-08-22 1981-03-28 Kyorin Pharmaceut Co Ltd Novel substituted quinolinecarboxylic acid and its preparation
JPS5746986A (en) * 1980-09-02 1982-03-17 Dai Ichi Seiyaku Co Ltd Pyrido(1,2,3-de)(1,4)benzoxazine derivative
US4670444B1 (en) * 1980-09-03 1999-02-09 Bayer Ag and-naphthyridine-3-carboxylic acids and antibacte7-amino-1-cyclopropyl-4-oxo-1,4-dihydro-quinoline-rial agents containing these compounds
US4620007A (en) * 1980-09-03 1986-10-28 Bayer Aktiengesellschaft 6-fluoro-7-chloro-1-cyclopropyl-4-oxo-1,4-dihydro-quinoline-3-carboxylic acid
DE3142854A1 (de) * 1981-10-29 1983-05-11 Bayer Ag, 5090 Leverkusen 1-cyclopropyl-6-fluor-1,4-dihydro-4-oxo-7-piperazino-chinolin-3-carbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
SE440354B (sv) * 1981-02-19 1985-07-29 Kyorin Seiyaku Kk Kinolinkarboxylsyraderivat
NZ208470A (en) * 1983-07-18 1988-06-30 Abbott Lab 6-fluoro-1,4-dihydro-4-oxo-quinoline-3-carboxylic acid derivatives and antibacterial compositions containing such
US4730000A (en) * 1984-04-09 1988-03-08 Abbott Laboratories Quinoline antibacterial compounds
AU553415B2 (en) * 1983-09-19 1986-07-17 Abbott Japan Co., Ltd. 6-fluoro-1-4-dihydro-4-oxo-7-substituted piperazinyl- quinoline-3-carboxylic acids
US4551456A (en) * 1983-11-14 1985-11-05 Merck & Co., Inc. Ophthalmic use of norfloxacin and related antibiotics
US4774246A (en) * 1984-01-26 1988-09-27 Abbott Laboratories Quinoline antibacterial compounds
DE3577089D1 (de) * 1984-01-26 1990-05-17 Abbott Lab Antibakterielle chinolinderivate.
DE3517709A1 (de) * 1985-01-05 1986-07-10 Bayer Ag Basische zubereitungen von chinoloncarbonsaeuren
NO166131C (no) * 1985-06-20 1991-06-05 Daiichi Seiyaku Co Analogifremgangsmaate for fremstilling av s(-)-pyridobenzoksazinforbindelser.
DE3608745A1 (de) * 1985-07-24 1987-01-29 Bayer Ag Bakterizide zubereitungen zur anwendung auf dem gebiet der veterinaermedizin
DE3537761A1 (de) * 1985-10-24 1987-04-30 Bayer Ag Infusionsloesungen der 1-cyclopropyl-6-fluor-1,4-dihydro-4-oxo-7- (1-piperazinyl)-chinolin-3-carbonsaeure
AU594983B2 (en) 1985-10-29 1990-03-22 Dainippon Pharmaceutical Co. Ltd. Novel quinoline derivatives and processes for preparation thereof
DE3601566A1 (de) * 1986-01-21 1987-07-23 Bayer Ag Pharmazeutische zubereitungen von ciprofloxacin
DE3632222A1 (de) * 1986-09-23 1988-04-07 Bayer Ag Topisch anwendbare zubereitungen von gyrase-inhibitoren
DE3637649A1 (de) * 1986-10-13 1988-04-14 Uwe Dr Spohr Verwendung von 4-chinolon-derivaten zur bekaempfung von protozoen und helminthen
DE3704907A1 (de) * 1987-02-17 1988-08-25 Bayer Ag Topisch anwendbare zubereitungen von gyrase-inhibitoren in kombination mit kortikosteroiden
IT1231425B (it) * 1987-10-05 1991-12-04 Prodotti Antibiotici Spa Procedimento per la sintesi di un derivato dell'acido benzo (ij) chinolizin-2-carbossilico
DE3902079A1 (de) * 1988-04-15 1989-10-26 Bayer Ag I.m. injektionsformen von gyrase-inhibitoren
US4978661A (en) * 1988-09-29 1990-12-18 Innocenzo Caruso Use of 6-halo-4-quinolone compounds and pharmaceutical compositions thereof for the preparation of a medicament for the therapeutical application in rheumatoid arthritis

Also Published As

Publication number Publication date
EP0437128A2 (fr) 1991-07-17
IE64720B1 (en) 1995-08-23
IL96618A (en) 1995-05-26
FR2655545A1 (fr) 1991-06-14
ZA909886B (en) 1991-09-25
KR910011259A (ko) 1991-08-07
HU207947B (en) 1993-07-28
PT96164B (pt) 1998-04-30
IL96618A0 (en) 1991-09-16
DE69006707D1 (de) 1994-03-24
FR2655545B1 (fr) 1994-06-10
IE904449A1 (en) 1991-06-19
HU908146D0 (en) 1991-06-28
HUT55991A (en) 1991-07-29
DE69006707T2 (de) 1994-06-09
CA2031886A1 (fr) 1991-06-12
PT96164A (pt) 1991-09-30
EP0437128A3 (en) 1992-09-30
ATE101518T1 (de) 1994-03-15
AU626743B2 (en) 1992-08-06
EP0437128B1 (fr) 1994-02-16
US5179096A (en) 1993-01-12
ES2062464T3 (es) 1994-12-16
AU6786290A (en) 1991-06-13
JPH03251532A (ja) 1991-11-11

Similar Documents

Publication Publication Date Title
DK0513104T3 (da) Anvendelse af et alfa-tocopherolphosphat eller et af dets derivater til fremstilling af kosmetiske, dermatologiske eller farmaceutiske præparater, og således opnåede præparater
ES530902A0 (es) Procedimiento para preparar derivados de piperazina
HUP9801356A2 (hu) Triciklusos (2-hidroxi-2-metil-3,3,3-trifluor-propanoil)-amino-benzoxepin-, -benzotiepin-, -benzocikloheptén-, -indén-származékok és az ezeket tartalmazó gyógyszerkészítmények
DK0649418T3 (da) 7-(2-aminoethyl)benzothiazolon
DK0437128T3 (da) Anvendelse af et fluorquinolonderivat til fremstilling af et lægemiddel til behandling af pneumocystosis
ATE78470T1 (de) Imidazolin-derivate und verfahren zu deren herstellung.
DE69004815D1 (de) 1,8-Benzonaphthyridinderivate, ihre Herstellung und diese enthaltende Zusammensetzungen.
DK0528164T3 (da) Anvendelse af xanthinderivater til fremstilling af et lægemiddel til behandling af sekundære nervecelleskader og funktionsforstyrrelser efter kranie-hjerne-traumer
DE69102477D1 (de) 3-Aminochroman-Derivate, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammensetzungen.
NO158459C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive fenyl-cyklobutanderivater.
ATE68494T1 (de) Benzofuranderivate und diese enthaltende therapeutische mittel.
ES491915A0 (es) Procedimiento para la preparacion de derivados de xantina
NO147877C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,4-oksazepin-derivater
DE68906827D1 (de) Phenothiazinderivate, deren herstellung und sie enthaltende pharmazeutische zusammensetzungen.
SE8302452D0 (sv) Method for treatment of senile dementia
DK0461012T3 (da) Derivater af ((1-arylpyrrolidin-2-yl)methyl)piperazin, fremstillingen heraf og deres terapeutiske anvendelse
TH20908B (th) อนุพันธ์คาร์โบไฮเดรต